Additionally, as for CMT2D mice, activation of the ISR was detected in homozygous Yars1E196K mice, however the therapeutic benefit of GCN2 inhibition is yet to be tested in this model (Spaulding et al., 2021). The gene discussed is EIF2AK4; the disease is Autosomal dominant Charcot-Marie-Tooth disease type 2D.